1,283
Participants
Start Date
April 30, 2007
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
Non-interventional study.
This is a non-interventional (no drug treatment administered), prevalence (observational) study.
GSK Investigational Site, Clairton
GSK Investigational Site, Harleysville
GSK Investigational Site, Newport News
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Raleigh
GSK Investigational Site, Mooresville
GSK Investigational Site, Salisbury
GSK Investigational Site, Charlotte
GSK Investigational Site, Sylva
GSK Investigational Site, Spartanburg
GSK Investigational Site, Union
GSK Investigational Site, Gaffney
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Greenville
GSK Investigational Site, Miami
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Clearwater
GSK Investigational Site, Largo
GSK Investigational Site, Harleysville
GSK Investigational Site, Bristol
GSK Investigational Site, Milan
GSK Investigational Site, Columbus
GSK Investigational Site, Beachwood
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dayton
GSK Investigational Site, Kettering
GSK Investigational Site, Dayton
GSK Investigational Site, Elkhart
GSK Investigational Site, Evansville
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Minneapolis
GSK Investigational Site, Rochester
GSK Investigational Site, Missoula
GSK Investigational Site, Vernon Hills
GSK Investigational Site, Gillespie
GSK Investigational Site, Nixa
GSK Investigational Site, Arkansas City
GSK Investigational Site, Wichita
GSK Investigational Site, Fremont
GSK Investigational Site, Sunset
GSK Investigational Site, Yukon
GSK Investigational Site, Plano
GSK Investigational Site, Wheat Ridge
GSK Investigational Site, Highlands Ranch
GSK Investigational Site, Gig Harbor
GSK Investigational Site, Tacoma
GSK Investigational Site, Cumberland
Lead Sponsor
GlaxoSmithKline
INDUSTRY